224 related articles for article (PubMed ID: 22015098)
1. Masked hyperprolactinemia: tumor-derived factors inhibiting prolactin secretion caused by pituitary-stalk damage.
Kinoshita Y; Hama S; Tominaga A; Arita K; Sugiyama K; Sakoguchi T; Usui S; Kurisu K
J Clin Neurosci; 2011 Dec; 18(12):1651-5. PubMed ID: 22015098
[TBL] [Abstract][Full Text] [Related]
2. [Influence of hyperprolactinemia and tumoral size in the postoperative pituitary function in clinically nonfunctioning pituitary macroadenomas].
Fonseca AL; Chimelli L; Santos MJ; Santos AA; Violante AH
Arq Neuropsiquiatr; 2002 Sep; 60(3-A):590-602. PubMed ID: 12244397
[TBL] [Abstract][Full Text] [Related]
3. Hyperprolactinaemia in patients with pituitary adenomas. The pituitary stalk compression syndrome.
Kruse A; Astrup J; Gyldensted C; Cold GE
Br J Neurosurg; 1995; 9(4):453-7. PubMed ID: 7576271
[TBL] [Abstract][Full Text] [Related]
4. Basal, pulsatile, entropic, and 24-hour rhythmic features of secondary hyperprolactinemia due to functional pituitary stalk disconnection mimic tumoral (primary) hyperprolactinemia.
Veldman RG; Frölich M; Pincus SM; Veldhuis JD; Roelfsema F
J Clin Endocrinol Metab; 2001 Apr; 86(4):1562-7. PubMed ID: 11297584
[TBL] [Abstract][Full Text] [Related]
5. Time Course of Resolution of Hyperprolactinemia After Transsphenoidal Surgery Among Patients Presenting with Pituitary Stalk Compression.
Zaidi HA; Cote DJ; Castlen JP; Burke WT; Liu YH; Smith TR; Laws ER
World Neurosurg; 2017 Jan; 97():2-7. PubMed ID: 27671881
[TBL] [Abstract][Full Text] [Related]
6. The dominant role of increased intrasellar pressure in the pathogenesis of hypopituitarism, hyperprolactinemia, and headaches in patients with pituitary adenomas.
Arafah BM; Prunty D; Ybarra J; Hlavin ML; Selman WR
J Clin Endocrinol Metab; 2000 May; 85(5):1789-93. PubMed ID: 10843153
[TBL] [Abstract][Full Text] [Related]
7. The hook effect in prolactin immunoassays.
Al Sifri SN; Raef H
Saudi Med J; 2004 May; 25(5):656-9. PubMed ID: 15138537
[TBL] [Abstract][Full Text] [Related]
8. Hyperprolactinemia, intrasellar pituitary tissue pressure, and the pituitary stalk compression syndrome.
Lees PD; Pickard JD
J Neurosurg; 1987 Aug; 67(2):192-6. PubMed ID: 3598680
[TBL] [Abstract][Full Text] [Related]
9. Pituitary imaging is indicated for the evaluation of hyperprolactinemia.
Bayrak A; Saadat P; Mor E; Chong L; Paulson RJ; Sokol RZ
Fertil Steril; 2005 Jul; 84(1):181-5. PubMed ID: 16009175
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging measurements of pituitary stalk compression and deviation in patients with nonprolactin-secreting intrasellar and parasellar tumors: lack of correlation with serum prolactin levels.
Smith MV; Laws ER
Neurosurgery; 1994 May; 34(5):834-9; discussion 839. PubMed ID: 8052379
[TBL] [Abstract][Full Text] [Related]
11. [Preservation of pituitary stalk in the microsurgery of giant pituitary adenoma and its significance].
Jia GJ; Wan WQ; Ni M; Jia W; Zhou DB; Zhang BK; Guan SS; Zhang JT
Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(23):1627-9. PubMed ID: 19035104
[TBL] [Abstract][Full Text] [Related]
12. Surgical treatment of prolactin-secreting pituitary adenomas: early results and long-term outcome.
Losa M; Mortini P; Barzaghi R; Gioia L; Giovanelli M
J Clin Endocrinol Metab; 2002 Jul; 87(7):3180-6. PubMed ID: 12107221
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the responses in the nomifensine test with hyperprolactinemia due to prolactin-secreting pituitary tumors and nonprolactin-secreting hypothalamic tumors.
Kamoi K; Tchuchida I; Sato H; Tanaka R; Ishiguro T; Kaneko K; Iwasaki Y; Shibata A
J Clin Endocrinol Metab; 1981 Dec; 53(6):1285-7. PubMed ID: 7298805
[TBL] [Abstract][Full Text] [Related]
14. Long term follow-up of women with surgically treated prolactin-secreting pituitary tumors.
Schlechte JA; Sherman BM; Chapler FK; VanGilder J
J Clin Endocrinol Metab; 1986 Jun; 62(6):1296-301. PubMed ID: 3084539
[TBL] [Abstract][Full Text] [Related]
15. Pituitary enlargement with suprasellar extension in functional hyperprolactinemia due to lactotroph hyperplasia: a pseudotumoral disease.
Peillon F; Dupuy M; Li JY; Kujas M; Vincens M; Mowszowicz I; Derome P
J Clin Endocrinol Metab; 1991 Nov; 73(5):1008-15. PubMed ID: 1939514
[TBL] [Abstract][Full Text] [Related]
16. Pulsatile prolactin secretion in hyperprolactinemia due to presumed pituitary stalk interruption.
Samuels MH; Henry P; Kleinschmidt-Demasters B; Lillehei K; Ridgway EC
J Clin Endocrinol Metab; 1991 Dec; 73(6):1289-93. PubMed ID: 1955511
[TBL] [Abstract][Full Text] [Related]
17. Pituitary prolactin producing adenoma with ossification: a rare histological variant and review of literature.
Ke C; Deng Z; Lei T; Zhou S; Guo DS; Wan J; Wu S
Neuropathology; 2010 Apr; 30(2):165-9. PubMed ID: 19737358
[TBL] [Abstract][Full Text] [Related]
18. Tumor tissue identification in the pseudocapsule of pituitary adenoma: should the pseudocapsule be removed for total resection of pituitary adenoma?
Lee EJ; Ahn JY; Noh T; Kim SH; Kim TS; Kim SH
Neurosurgery; 2009 Mar; 64(3 Suppl):ons62-9; discussion ons69-70. PubMed ID: 19240574
[TBL] [Abstract][Full Text] [Related]
19. Plasma levels of parathyroid hormone-related peptide are elevated in hyperprolactinemia and correlated to bone density status.
Stiegler C; Leb G; Kleinert R; Warnkross H; Ramschak-Schwarzer S; Lipp R; Clarici G; Krejs GJ; Dobnig H
J Bone Miner Res; 1995 May; 10(5):751-9. PubMed ID: 7639111
[TBL] [Abstract][Full Text] [Related]
20. [Primary hypothyroidism presenting with amenorrhea, galactorrhea, hyperprolactinemia and enlarged pituitary].
Tadmor OP; Barr I; Diamant YZ
Harefuah; 1992 Jan; 122(2):76-8. PubMed ID: 1572562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
